The Journal of Experimental Medicine
VeriKine-HS Human IFN-Beta
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents
Published 2 February 2004. doi:10.1084/jem.20031228
Rockefeller University Press, 0022-1007 $8.00
JEM, Volume 199, Number 3, 429-434
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 231K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zakaria, S.
Right arrow Articles by Billadeau, D. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zakaria, S.
Right arrow Articles by Billadeau, D. D.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Brief Definitive Report

 Differential Regulation of TCR-mediated Gene Transcription by Vav Family Members

Shaheen Zakaria1, Timothy S. Gomez2, Doris N. Savoy1, Simon McAdam3, Martin Turner3, Robert T. Abraham4, and Daniel D. Billadeau1,2

1 Division of Developmental Oncology Research, Mayo Clinic College of Medicine, Rochester, MN 55905
2 Department of Immunology, Mayo Clinic College of Medicine, Rochester, MN 55905
3 Lymphocyte Signaling and Development Laboratory, Molecular Immunology Programme, Babraham Institute, Babraham, Cambridge CB2 4AT, UK
4 The Burnham Institute, La Jolla, CA 92037

Address correspondence to Daniel D. Billadeau, Div. of Oncology Research, Mayo Clinic, 200 First St. SW, Rochester, MN 55905. Phone: (507) 266-4334; Fax: (507) 266-5146; email: billadeau.daniel{at}mayo.edu

Although all three Vav family members are expressed in T lymphocytes, the role that Vav3 plays in T cell activation is poorly defined. Here we show that, like Vav1, Vav3 undergoes rapid tyrosine phosphorylation after T cell receptor (TCR) cross-linkage and interacts with the adaptor molecules SLP76 and 3BP2 in a SH2-dependent manner. However, depletion of Vav1 but not Vav3 protein by RNA interference affects TCR-mediated IL-2 promoter activity. In contrast, Vav3 function is specifically required for coupling TCR stimulation to serum response element–mediated gene transcription. These data indicate that, although both Vav proteins are biochemically coupled to the TCR, they regulate distinct molecular pathways leading to defined gene transcriptional events.

Key Words: T cell • signal transduction • Vav • GEF • SRE


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS